Intensity-modulated Radiotherapy in the Treatment of Breast Cancer

Clinical Oncology

Volumn 24, Issue 7, 2012, Pages 488-498

  Dayes, I ^a   Rumble, R B ^b   Bowen, J ^c   Dixon, P ^d   Warde, P ^e  

^a MCMASTER UNIVERSITY   (Canada)

^b Cancer Care Ontarios Program in Evidence based Care   (Canada)

^c Northeastern Ontario Regional Cancer Centre   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

^e Radiation Treatment Program   (Canada)

Author keywords

Best practice; Breast cancer; Clinical practice guideline; Evidence based medicine; IMRT; Intensity modulated radiotherapy; Radiation treatment

Indexed keywords

ACUTE TOXICITY; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELLULITIS; DERMATITIS; DESQUAMATION; EDEMA; FAT NECROSIS; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INTENSITY MODULATED RADIATION THERAPY; LYMPHEDEMA; PAIN; PRIORITY JOURNAL; RADIATION PNEUMONIA; SKIN INDURATION; SKIN TOXICITY;

BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84864751382     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.05.003     Document Type: Article

References (23)

1. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists Collaborative Group. New Eng J Med 1995, 333(22):1444-1455. Early Breast Cancer Trialists Collaborative Group.
2. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366(9503):2087-2106.
3. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. New Engl J Med 1997, 337(14):949-955.
4. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. New Engl J Med 1997, 337(14):956-962.
5. Whelan T.J., Julian J., Wright J., Jadad A.R., Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000, 18(6):1220-1229.
6. Giordano S.H., Kuo Y.F., Freeman J.L., et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005, 97(6):419-424.
7. Taylor C.W., Nisbet A., McGale P., et al. Cardiac doses from Swedish breast cancer radiotherapy since the 1950s. Radiother Oncol 2009, 90(1):127-135.
8. Kam M.K., Leung S.F., Zee B., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007, 25(31):4873-4879.
9. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000, 55(3):241-249.
10. Hartford A.C., Palisca M.G., Eichler T.J., et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice guidelines for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys 2009, 73(1):9-14.
11. Whitton A., Warde P., Sharpe M., et al. Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. Clin Oncol 2009, 21(3):192-203.
12. Browman G.P., Levine M.N., Mohide E.A., et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995, 13(2):502-512.
13. Bauman G., Rumble R.B., Chen J., et al. Intensity-modulated radiotherapy in the treatment of prostate cancer. Clin Oncol 2012, 24. 000-000.
14. Freedman G., Li T., Nicolaou N., Anderson P. Breast IMRT reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys 2007, 49(Suppl.):S207. S8.
15. Freedman G.M., Anderson P.R., Li J., et al. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol 2006, 29(1):66-70.
16. Harsolia A., Kestin L., Grills I., et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 2007, 68(5):1375-1380.
17. McDonald M.W., Godette K.D., Butker E.K., et al. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis. Int J Radiat Oncol Biol Phys 2008, 72(4):1031-1040.
18. Morganti A.G., Cilla S., Valentini V., et al. Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. Radiother Oncol 2009, 90(1):86-92.
19. Pignol J.P., Olivotto I., Rakovitch E., et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008, 26(13):2085-2092.
20. Freedman G.M., Li T., Nicolaou N., Chen Y., Ma C.C.M., Anderson P.R. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys 2009, 74(3):689-694.
21. Baker S.G., Lindeman K.S. Rethinking historical controls. Biostatistics 2001, 2(4):383-396.
22. Kunz R., Vist Gunn E., Oxman Andrew D. Randomisation to protect against selection bias in healthcare trials [Article No. MR000012]. Cochrane Database Sys Rev 2007, Available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/MR000012/frame.html.
23. Donovan E., Bleakley N., Denholm E., et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007, 82(3):254-264.